Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EBI3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | MYL10 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TIAM1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ATAD5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PDZD3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZNF80 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | BMP2K | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CXCL9 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | SLAMF9 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZNF24 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |